Live from the NIH registry
Studies recruiting near Ogden right now
Top 25 of 116 recruiting studies, sorted by proximity — each links to its official registry page
Adaptation and Pilot Implementation of ePNa Clinical Decision Support for Utah Urgent Care Clinics
Pneumonia
N/A
Interventional 4,000 participants sought
South Ogden Instacare — South Ogden, Utah (2.5 mi)
· Sponsor: Intermountain Health Care, Inc.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
McKay-Dee Hospital Center — Ogden, Utah (0.4 mi)
· Sponsor: NRG Oncology
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma
Phase 3
Interventional 336 participants sought
Farmington Health Center — Farmington, Utah (17.6 mi)
· Sponsor: National Cancer Institute (NCI)
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Care Access - Ogden — Ogden, Utah (0.4 mi)
· Sponsor: Eli Lilly and Company
An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease
Dry Eye Disease (DED)
Phase 2
Interventional 417 participants sought
Alpine Research Organization, Inc. — Clinton, Utah (7.4 mi)
· Sponsor: Dompé Farmaceutici S.p.A
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Alopecia Areata
Phase 3
Interventional 1,330 participants sought
AMR Clinical — Layton, Utah (11.6 mi)
· Sponsor: Pfizer
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,260 participants sought
McKay-Dee Hospital Center — Ogden, Utah (0.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
Farmington Health Center — Farmington, Utah (17.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Diffuse Large B-cell Lymphoma (DLBCL)
Phase 3
Interventional 904 participants sought
Community Cancer Trials of Utah — Ogden, Utah (0.4 mi)
· Sponsor: Regeneron Pharmaceuticals
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
Advanced Research Institute - Ogden — Ogden, Utah (0.4 mi)
· Sponsor: vTv Therapeutics
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Layton, Utah (11.6 mi)
· Sponsor: Alnylam Pharmaceuticals
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Cope Family Medicine-Site Number : 8400053 — Bountiful, Utah (23.8 mi)
· Sponsor: Sanofi
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Irritable Bowel Syndrome
Phase 2
Interventional 420 participants sought
GSK Investigational Site — Ogden, Utah (0.4 mi)
· Sponsor: GlaxoSmithKline
Brexanolone Lifting Outcomes Of Moms
Depression, Postpartum, Postpartum Depression (PPD)
Phase 3
Interventional 120 participants sought
Lipocine Investigational Site — Clinton, Utah (7.4 mi)
· Sponsor: Lipocine Inc.
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Alzheimer Disease, Agitation
Phase 3
Interventional 650 participants sought
Local Institution - 2612 — Bountiful, Utah (23.8 mi)
· Sponsor: Bristol-Myers Squibb
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia
Phase 3
Interventional 303 participants sought
McKay-Dee Hospital Center — Ogden, Utah (0.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Platform of Randomized Adaptive Clinical Trials in Critical Illness
Respiratory Insufficiency, Extracorporeal Membrane Oxygenation Complication
N/A
Interventional 6,250 participants sought
University of Utah Health — Farmington, Utah (17.6 mi)
· Sponsor: University Health Network, Toronto
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Alpine Research Organization - Clinton /ID# 276527 — Clinton, Utah (7.4 mi)
· Sponsor: AbbVie
A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
Ulcerative Colitis
Phase 2
Interventional 99 participants sought
Investigational Site Number: 8400007 — Ogden, Utah (0.4 mi)
· Sponsor: Sanofi
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors
Advanced Solid Tumors
Phase 1
Interventional 220 participants sought
START Mountain — Ogden, Utah (0.4 mi)
· Sponsor: Vividion Therapeutics, Inc.
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Ogden, Utah (0.4 mi)
· Sponsor: 89bio, Inc.
Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age
Pneumococcal Immunization, Healthy Volunteers
Phase 3
Interventional 2,195 participants sought
Rio Clinical Trials - Canyon View- Site Number : 8400031 — Ogden, Utah (0.4 mi)
· Sponsor: Sanofi
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Pancreatic Acinar Cell Carcinoma, Pancreatic Adenosquamous Carcinoma
Phase 2
Interventional 152 participants sought
Farmington Health Center — Farmington, Utah (17.6 mi)
· Sponsor: National Cancer Institute (NCI)
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
Advanced Research Institute — Ogden, Utah (0.4 mi)
· Sponsor: Kallyope Inc.
Evaluation of Outcomes Following In-office Tympanostomy Using the Tula® System: a Prospective, Multi-center Registry
Otitis Media With Effusion, Acute Otitis Media
N/A
Observational 200 participants sought
Ogden Clinic - Professional Center North — Ogden, Utah (0.4 mi)
· Sponsor: Smith & Nephew, Inc.